Arbutus Biopharma
ABUS
ABUS
160 hedge funds and large institutions have $364M invested in Arbutus Biopharma in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 66 increasing their positions, 42 reducing their positions, and 18 closing their positions.
Holders
160
Holders Change
-7
Holders Change %
-4.19%
% of All Funds
2.15%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
13
Increased
66
Reduced
42
Closed
18
Calls
$2.44M
Puts
$1.53M
Net Calls
+$915K
Net Calls Change
+$80K
Top Buyers
1 |
![]()
1
Adage Capital Partners
Boston,
Massachusetts
|
$7.96M |
2 |
TSC
2
Two Seas Capital
Rye,
New York
|
$32.3M |
3 |
3
Goldman Sachs
New York
|
$9.39M |
4 |
4
UBS AM
Chicago,
Illinois
|
$3.31M |
5 |
ACM
5
ADAR1 Capital Management
Austin,
Texas
|
$8.73M |